Although data are somewhat outdated due to lack of regular national monitoring in the country, Japan is in the best 4 countries for five-year survival estimate for cervical and breast cancer in the 2000s. With regards to colorectal cancer, Japan has attained five-year survival estimate over 65% for both men and women in the early 2000s, which is above the OECD average of 61.3% for men and 63.3% for women in the late 2000s. A striking feature of the Japanese hospital sector is the high in-hospital case fatality rates for acute myocardial infarction (AMI). Although Japanese are less likely to die of ischemic heart disease compared to people in other OECD countries, they are more likely to die once admitted into hospital for AMI than patients in other OECD countries.